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Summary 
Emodin (1,6,8-trihydroxy-3-methylanthraquinone), an important aglycone found in natural anth-
raquinone glycosides frequently used in Iaxative drugs, was mutagenic in the Salmonellajmammalian 
microsome assay (Ames test) with a specificity for strain TA1537. The mutagenic activity was activation-
dependent with an optimal amount of S9 from Aroclor 1254-treated male Sprague-Dawley rats of 20% in 
the S9 mix (v jv) for 10 p.g emodin per plate. Heat inactivation of the S9 for 30 min at 60 ° C prevented 
mutagenicity. The addition of the cytochrome P-448 inhibitor 7,8-benzoflavone (18.5 nmoles per plate) 
reduced the mutagenic activity of 5.0 p.g emodin per plate to about one third, whereas the P-450 inhibitor 
metyrapone (up to 1850 nmoles per plate) was without effect. To test whether a metabolite" binds 
covalently to Salmonella DNA, [10-14C]emodin was radiosynthesized, large batches of bacteria were 
incubated with [10-14C]emodin and DNA was isolated. [G- 3H]Aflatoxin B1 (AFB1) was used as a positive 
control mutagen known to act via DNA binding. DNA obtained after aflatoxin treatment could be 
purified to constant specific activity. With emodin, the specific activity of DNA did not remain coi:lstant 
after repeated precipitations so that it is unlikely that the mutagenicity of emodin is due to covalent 
interaction .of a metabolite with DNA. The antioxidants vitamin C and E or glutathione did not reduce the 
mutagenicity. Emodin was also negative with strain TA102. Thus, oxygen radicals are probably not 
involved. When emodin was incubated with S9 alone for up to 50 h before heat-inactivation of the 
enzymes and addition of bacteria, the mutagenic activity did not decrease. lt is concluded that the 
mutagenicity of emodin is due to a chemically stable, oxidized metabolite forming physico-chemical 
associations with DNA, possibly of the intercalative type. In order to check whether an intact mammalian 
organism might be able to activate emodin to a DNA-binding metabolite, radiolabelled emodin was 
administered by oral gavage to male SD rats and liver DNA was isolated after 72 h. Very little 
radioactivity was associated with the DNA. Considering that DNA radioactivity could also be due to 
sources other than covalent interactions, an upper limit for the · covalent binding index, CBI = (p.moles 
chemical bound per moles DNA nucleotides)/(mmoles chemical administered per kg body weight) of 0.5 
is deduced. This is 104 times below the CBI of AFB1. The demonstration of a lack of covalent interaction 
with DNA bothin Salmonellaandin rat liver is discussed in terms of a reduced hazard posed by emodin 
as a mutagenic drug in use in humans. 
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Emodin (1,6,8-trihydroxy-3-methylanthraqui· 
none) is an important aglycone found in natural 
anthraquinone glycosides. 1,8-Dihydroxyanthra· 
quinones of plants belanging to the families of 
Alloe, Cassia, Rhamnus and Rheum are fre-
quently used as Iaxative drugs. About 70% of this 
kind of drug used in Switzerland contain anthra-
quinone derivatives (Codex Galenica, 1984). Fur-
thermore, natural and synthetic anthraquinones 
are used as colouring agents in the food, cosmet-
ics, and textile industries. Some anthraquinone 
derivatives are also used as cytostatics (Traganos, 
1983) or show cytostatic activity in vivo (Driscoll 
et al., 1974). A high percentage of anthraquinone 
compounds exhibit mutagenicity in the Salmonel-
la/ mammalian microsome assay (Ames test). The 
majority including emodin is active with strain 
TA1537 (Brown and Brown, 1976; Brown and 
Dietrich, 1979; Tikkanen et al., 1983) which is 
reverted by intercalating agents such as 9-
aminoacridine (Ames et al., 1973). The strain 
specificity disappears by the substitution of 
anthraquinones with amino groups which Ieads to 
mutagenicity also with TA98 and TA1538 (Brown 
and Brown, 1976; Brown and Dietrich, 1979). The 
mutagenic activity of emodin is dependent on the 
addition of an activation system (Wehner et al., 
1979; Brown, 1980; Libermann et al., 1982). No 
carcinogenic effects were found in a study con-
ducted by Saffiotti and Shubik (1963) in mouse 
skin. 
A great nurober of mutagens react covalently 
with DNA. If this type of genotoxic activity can 
be shown to be the mechanism of mutagenic ac-
tion of emodin, a human exposure to anthraqui-
nones would have to be considered in terms of a 
carcinogenic hazard despite the so far negative 
evidence in animal studies. The mechanism of 
mutagenic action of emodin in the Ames test and 
its ability to bind covalently to DNA of Salmonella 
and in rat liver was therefore investigated. 
Materials and methods 
Chemieals and apparatus. Emodin, ascorbic 
acid (vitamin C) and DMSO were obtained from 
Fluka AG, Buchs (Switzerland). Adriamycin was 
obtained from Farmitalia, Milano (ltaly). Aflato-
xin B1 (AFB1) was purchased from Senn AG, 
Dielsdorf (Switzerland). Glutathione, NADP, glu-
cose 6-phosphate, biotin, vitamin E ( d/-a.-
tocopherol) and SDS were obtained from Sigma, 
St. Louis, MO (U.S.A.). Hydrogen peroxide and 
silicagel plates were from Merck, Darmstadt, 
(F.R.G.), who also supplied all Standard reagents 
of the highest purity available. 
[G- 3H]-Labelled aflatoxin B1, specific activity 8 
Cijmmole, was purchased from Moravek Bio-
chemicals, Brea, CA (U.S.A.). It was diluted with 
unlabelled AFB1 to a specific activity of 61 
mCijmmole. 
Radioactivity measurements were carried out in 
Insta-Gel (Packard Instruments, Downers Grove, 
IL, U.S.A.) in a liquid scintillation counter, 
Packard Tri Carb 460 CD. 
Synthesis of [ 14Cjemodin. [10-14 C]Emodin (I) 
was synthesized from 3,5-dimethoxybenzoic[14 C]-
acid methylester (II) and 2-methoxy-4-methyl ben-
zoyl chloride (111) adapting the method of Hirose 
et al. (1973) to a millimolar scale: 3,5-di-
methoxyaniline was converted by a Sandmeier 
reaction to 1-bromo-3,5-dimethoxybenzene which 
was Iabelied with [14C]C02 (from BaC03 , 50 mCi) 
Chemical structure of emodin. 
according to the procedure of Nguyen-Hoang-
Nam et al. (1974) followed by esterification with 
diazomethane to II. li was then reacted with 111 in 
a Friedel-Crafts acylation reaction and the result-
ing crude product subjected to ring condensation 
in a malten mixture of AIC1 3/N aCl. I was isolated 
from other anthraquinone compounds by colurnn 
chromatography (benzene : ethyl acetate : acetic 
acid 90 : 10 : 1) on silica and recrystallized from 
CHC1 3 : MeOH (95 : 5) to yield chemically pure I 
as characterized by MS, IR and m.p. 
The radiochemical purity was > 99% as checked 
by thffi-layer chromatography on silica gel plates 
with toluene: ethyl acetate: acetic acid (5: 4: 1) 
and benzene : methanol (7 : 2). The specific activ-
ity was 17.4 mCijmmole. 
Bacteria and activation system. Salmonella 
typhimurium strains TA1537, TA1977, TA1538, 
TA98, TA1535, TA100 and TA102 were kindly 
provided by B.N. Ames, University of California, 
Berkeley, CA (U.S.A.). Liver homogenate frac-
tions (9000 g supematant prepared according to 
Ames et al., 1975) from Aroclor 1254-induced 
male Sprague-Dawley rats were used. 
Standard Ames test and preincubation assay. 
Mutagenicity of emodin, adriamycin and hydro-
gen peroxide was determined using the plate-in-
corporation test as described by Ames et al. (1975). 
The influence of the S9 concentration in the S9 
mix (usually 10% [v jv]) on the mutagenicity of 
emodin in TA1537 was tested with the preincuba-
tion method (30 min at 37 o C) of Y ahagi et al. 
(1977). 
Mutagenicity and DNA binding. For the 
simultaneaus determination of mutagenic effects 
and binding to bacterial DNA, the liquid prein-
cubation method of Yahagi et al. (1977) was mod-
ified. Bacteria were grown overnight in 21 nutrient 
broth and the suspension was concentrated before 
use 10-fold by centrifugation and resuspension in 
200 ml medium. Based on the composition used 
for one plate in the Ames agar plate assay (0.5 ml 
S9 mix, 0.1 m1 bacteria and 50 p.l solution of the 
substance in DMSO; final vol. 0.65 ml), a 500-fold 
volume (325 ml) was used. The mixtures contain-
ing 9.25 JLmoles [14C]emodin or 0.48 p.moles 
[ 3 H]aflatoxin B1 were incubated in the dark for 90 
min in a shaking water bath (100 cyclesjmin; 
37°C). 
In the reaction mixtures without metabolic 
activation, a heat-inactivated S9 (30 min at 60 °) 
without cofactors was used in order to have an 
equal protein concentration. The lass of enzymatic 
activity was confirmed by the absence of mutagen-
icity after incubation with 2-aminoanthracene (2-
AA), benzo[ a ]pyrene (BaP) and 7 ,12-dimethyl-
benz[a]anthracene (7,12-DMBA). 
For the determination of viable cell counts, 
aliquots of the reaction mixtures were ap-
propriately diluted with 0.85% (wjv) NaCl to 
approximately 500 cells per 0.1 ml and plated on 
minimal agar plates tagether with top agar supple-
mented with 0.3 mM histidine. Two independent 
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dilutions per incubation mixture were made. 
In order to determine the mutagenic effects, an 
aliquot of the incubation mixtures (5 m1 of 325 
ml) was centrifuged (2000 g for 20 min) im-
mediately after incubation. Bacteria were resus-
pended in 5 ml cold 0.85% NaCljDMSO (9: 1) 
and centrifuged again (2000 g for 20 min). The 
washed cells were resuspended in 5 ml cold 0.85% 
NaCl before plating (3 replicate plates). 
DNA was isolated from the bacterial pellet 
after centrifugation of the remaining incubation 
mixture at 8000 g for 10 min according to Viviani 
and Lutz (1978). 0.5-1 mg purified DNA was 
obtained per g wet bacterial pellet. The amount of 
DN A was determined by spectrophotometry on 
the basis of a UV absorbance of 20 at 260 nm for 
a solution of 1 mg/ml. Radioactivity was de-
termined by liquid-scintillation counting of an 
aliquot in 10 ml Insta-Gel (Packard). DNA was 
reprecipitated with ethanol and the specific activ-
ity was determined again. These steps were 
repeated to constant specific activity to make sure 
that only covalently bound radiolabet remained 
on the bacterial DNA. 
Influence of antioxidants. The effect of vita-
min C and E, and of glutathione (GSH) on TA1537 
revertants induced by emodin was tested in the 
preincubation assay. The emodin concentration in 
the incubation mixture was 0.06 mM. Concentra-
tions of vitamin C and E ranged from 0 to 6 mM, 
GSH concentration was 5 mM. 
Chemica/ stability of the mutagenic principle oj 
emodin. The Ames testwas modified in the fol-
lowing manner: Areaction mixture containing 15 
ml S9 mix and 0.15 mg of emodin (dissolved in 1.5 
m1 of DMSO) was held at 37 ° C. For the first 
experiment, aliquots of 1.65 ml were taken at 
various times up to 50 h, mixed with 0.3 ml 
overnight culture of TA1537 and plated together 
with 6 ml top agar (3 replicate plates). For the 
second experiment, the incubation mixture (S9 
and emodin) was incubated for 1 h at 37 ° C 
followed by 30 min at 60 ° C to inactivate the drug 
metabolism enzymes. The reaction mixture was 
then cooled to 37 ° C and kept at this temperature 
for up to 50 h. During this time aliquots of 1.65 
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ml were mixed with bacteria and top agar and 
were plated. 
DNA binding in rat liver. Two 250-g female 
Sprague-Dawley rats received by oral gavage in 
polyethylene glycol (PEG 400) 3.57 and 3.32 mCi 
[ 14 C]emodin per kg body weight (53 mgjkg). The 
animals were killed with ether after 72 h and 
DNA was isolated from the liver via chromatin 
according to Sagelsdorff et al. (1983). DNA iso-
lated from an untreated rat served as radioactivity 
background for the determination of the specific 
activity. 
Results 
Mutagenicity. Table 1 shows that emodin pro-
duced a clear mutagenic effect only with strain 
1537 and only in the presence of a mammalian 
activation system. A borderline effect was also 
observed with TAlOO and rat-liver activation. A 
linear dose-response relationship was seen up to 
10 p.g emodin per plate. In TA1537 the mutagenic 
activity with 10 p.g emodin per plate increased 
linearly with the concentration of S9 up to 10% in 
the S9 mix (Fig. 1). Between 10 and 20% the 
nurober of revertants increased very slowly and 
between 20 and 30% no further increase could be 
observed. The mutagenic activity of emodin could 
be achieved only in the presence of active S9; 
after the addition of heat-inactivated S9 (30 min, 
60 o C) no mutagenicity was detected (Table 2). 
Addition of the cytochrome-P448 inhibitor 7,8-
400 
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Fig. 1. Mutagenicity of emodin (2 J.Lg per plate [*]; 10 p.g per 
plate [D}; control [ 0]) after addition of S9 mix with different 
concentrations of S9 (% [v jv]). 
TABLE 1 
MUTAGENICITY OF EMODIN FOR DIFFERENT S 
typhimurium STRAINS 
Mean and standard deviation of triplicates. 
Dose Activa- Revertants per plate 
(J,tg) tion r TA1537 TA1538 TA98 TA1535 TA100 
Rat~ tver S9 
0 7 ± 1 20±3 15±6 66±5 192± 4 
+ 8± 1 30± 3 26±6 23± 1 200± 6 
2 9± 2 
+ 84± 11 
10 11 ± 4 
+ 427±34 
20 21±4 19±4 71±8 201± 5 
+ 31 ±7 28± 1 26±3 312±24 
40 15± 4 23±6 
+ 438±22 31 ± 1 
80 12± 5 30±9 14±2 62±8 209± 15 
+ 437±35 32±5 24±6 24±9 319± 29 
benzoflavone inhibited the mutagenic activity of 
emodin towards TA1537 (Fig. 2, left-hand side). 
The mutagenicity of BaP was also reduced by the 
addition of this inhibitor. Metyrapone, on the 
7,8-BENZOFLAVONE 
0 011) C? 
~ ~ CJ) 
rvnol irdlltor per plate 
Fig. 2. lnfluence of cytochrome P-448/P-450 inhibitors on the 
mutagenic activity of emodin (5 1-Lg per plate [D]) and two 
Standardpromutagens (5 p.g BaP per plate [*]; 1 J.Lg 2-AA per 
plate [0}). The test compounds were preincubated in a total 
volume of 1.8 ml containing 1.5 ml 10% (v jv) S9 mix and 
different amounts of the respective inhibitor for 30 min at 
37 ° C before the addition of 0.3 ml bacteria (TA1537 for 
emodin; TA98 for BaP and 2-AA) and 6.0 ml top agar. The 
suspension was thoroughly mixed and plated on 3 replicate 
plates. 
TABLE 2 
MUTAGENIC ACI1VITY OF EMODIN AND OF STAN-
DARD PROMUTAGENS AFI'ER ADDITION OF ACTIVE 




Emodin (10 j.Lg) TA1537 
2-AA (11-'g) TA1537 
BaP (5 p.g) TA98 
7,12-DMBA (10 11g) TA98 
Total number of revertants 
per plate 
inactiv. 
8±1 324±23 9±1 
8±1 33± 3 7±4 
22±4 628±33 26±5 
24±2 265±15 32±5 
a Addition of buffer instead of S9. 
other band, an inhibitor of the cytochrome P-450-
dependent moilooxygenases, did not reduce the 
mutagenicity of emodin or BaP. The mutagenic 
effect of 2-AA was even increased (Fig. 2, right-
hand side). It is concluded that the mutagenicity 
of emodin is dependent on a metabolic, oxidative · 




Mutagenicity and DNA binding. In order to 
investigate whether the observed mutagenicity in 
TA1537 was due to covalent DNA binding, 
e4 C]emodin was used in a large-scale incubation 
so that enough DNA could be isolated from the 
bacteria to detect bound emodin. The concentra-
tion of [3H]aflatoxin B1 used in parallel incuba-
tions as positive control was about 20 tinles lower 
to give approximately the same mutagenic re-
sponse as emodin. The data are presented in Table 
3. Mutagenicity of emodin and bacterial. survival 
were lower than in the standard tests, probably 
due to the additional washings. This was done to 
remove the test compounds from the preincuba-
tion mixture so that no additional mutagenicity 
could be exerted on the plates. 
DNA obtained from the aflatoxin-treated 
Salmonella could be purified to a constan t specific 
activity (after the 2nd precipitation) indicating 
that the mutagen was bound covalently. With 
emodin, the specific activity of DNA did not 
remain constant after repeated precipitations. Al-
ready after the 2nd precipitation no difference was 
seen between the incubation mixtures with active 
and heat-inactivated S9. This behaviour is not 
MUTAGENICITY AND DNA BINDING OF [14 C]EMODIN AND [3H]AFB1 IN TA1537 
E-
lncubation 
Mutagen in 325 ml incub. mix. (1-'moles) 9.25 
Spec. act. (10 7 dpm/1-'mole) 3.86 
Mutagenicity 
lnduced revertants per plate a 0 
DNA binding 
DNA (mg) isolated 4.2 
Specific activity (dpm per mg DNA) 
1st precipitation 11 
2nd precipitation 11 
3rd precipitation 7 
Bound mutagen (pmoles per mg DNA b) ~0.28 
Bound molecules per Salmonella genome b,c ~0.8 
E-, A -= Emodin resp. AFB1 incubated with heat-inactivated S9. 
E+, A +: Emodin resp. AFB1 incubated with active S9. 
E+ A- A+ 
9.25 0.48 0.48 
3.86 13.6 13.6 
11 0 64 
4.2 5.0 4.2 
17 <60 1150 
11 <60 1120 
6 constant 
~0.28 <0.44 8.5 
~0.8 <1.2 24 
a Induced revertants in 0.65 m1 incubation mix (the value for the sample with inactivated S9 was subtracted; mean values of 6 
replicate plates). 
b Related to the 2nd DNA precipitation. 
c Calculated on the assumption that the average molecular weight of one nucleotide is 309 and that the mean nucleotide content is 
9 x 106 per Salmonella genome (Drake, 1969). 
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compatible with a covalent binding so that the 
mutagenicity of the emodin metabolite is unlikely 
to involve covalent interaction with Salmonella 
DNA. 
lnfluence of antioxidants. The mutagenicity 
must therefore be due either to non-covalent inter-
action of an oxidized metabolite with DNA or to 
the production of oxygen-derived radicals which 
might be formed during emodin metabolism. The 
latter possibility was rendered unlikely, however, 
by the use of strain TA102 which should specifi-
cally be reverted by oxygen radical-generating 
compounds such as peroxides. Emodin was nega-
tive in this strain, and the two strains TA102 and 
TA1537 showed a completely different response 
pattem with H20 2 , adriamycin and emodin (Fig. 
3). Furthermore, the use of the antioxidants vita-
min C and E and of glutathione did not Iead to a 
decrease in the nurober of TA1537 revertants in-
duced by emodin (Table 4). 
TA102 
TA1537 
Test corT1)0U'Id per plate (pg) 
Fig. 3. Mutagenicity in the plate-incorporation procedure in 
Salmonella strains TA102 and TA1537 of emodin (0, S9- = S9+ 
with TA102, 59+ with TA1537), adriamycin (•, S9-=S9+), 
and hydrogen permüde (0, S9- with TA102, S9- =59+ with 
TA1537). Results of 2 independent experiments. 
TABLE 4 
THE INFLUENCE OF DIFFERENT ANTIOXIDANTS OR 
RADICAL SCAVENGERS ON THE MUTAGENIC ACTIV-
ITY OF EMODIN FOR TA1537 
Compound 












Total number of revertants per plate± SD 
Emodin ( p.g per plate) 
0 5 10 
10±3 351 ± 36 
7±5 329±22 




20±3 173± 10 232±23 
18±3 197± 8 264±21 
Bacteria, emodin, S9 mix and the different compounds were 
preincubated for 20 min at 37 ° C before plating. For the 
experiment with GSH a separate top agar layer containing S9, 
emodin and GSH was plated on the dried top agar containing 
bacteria. 
Chemica/ stability of the mutagenic principle oj 
emodin. The mutagenicity of emodin to TA1537 
was not reduced when the bacteria were added to 
the incubation mixture only after preincubation of 
emodin with S9 and heat inactivation of the en-
zymes (Fig. 4; *). The same value of stable muta-
genicity was also obtained when the preincubation 
of emodin and S9 Iasted between 6 and 50 h 
before the addition of TA1537 and plating (no 
heat inactivation; Fig. 4; 0). The higher mutagen-
icity obtained after preincubation of emodin and 
S9 for up to 6 h can be interpreted as a result of 
additional activation on the plates. The continu-
ous decrease of the mutagenic activity between 1 · 
and 6 h is most probably due to the slow inactiva-
tion of the monooxygenases at 37 ° C. The most 
important point of the results presented in Fig. 4 
is, however, the fact that the mutagenic principle 
produced by emodin in the presence of rat-liver 
enzymes must be stable. This stability would not 
have been expected with oxygen radicals. 
DNA binding in rat liver. The specific activity 




0 1 2 4 6 24 
Prelncubatlon perlod 
SOh 
Fig. 4. Stability of the mutagenic emodin metabolites. Prein-
cubation of emodin and S9 mix at 37 o C and deterrnination of 
the mutagenic activity after different incubation periods before 
the addition of bacteria ( 0 ). Heat inactivation (30 min, 60 ° C) 
of the suspension coniaining S9 mix and emodin after 1 h at 
37 ° C and determination of the mutagenic activity thereafter 
(*). 
This was too low for a nucleotide analysis which 
would have allowed the subtraction ofthat part of 
the radioactivity which might have been incorpo-
rated into DNA from radiolabelled breakdown 
products by de novo DNA synthesis. Expressed in 
the units of the Covalent Binding Index (Lutz, 
1979), CBI = (J.Lmoles chemical bound per mole 
DNA-nucleotides)j(mmoles chemical admin-
istrated per kg body weight) upper Iimit values of 
0.5 and 0.9 resulted. This is about 10000 times 
below the CBI for af.latoxin B1 (Lutz, 1979) and in 
a range which makes it highly unlikely that coval-
ent binding willlead to increased tumour forma-
tion in a standard bioassay on carcinogenicity. 
Discussion 
The results of the present work suggest that the 
observed mutagenicity of emodin is a result of a 
stable oxidation product formedunder the control 
of cytochrome P448-dependent monooxygenases. 
Because of the much stronger response of strain 
TA1537 in comparison to TA100 and because of 
the Iack of covalent reactivity with DNA, the 
responsible emodin metabolite(s) most probably 
induce exclusively frameshift-type mutations as a 
consequence of a physico-chemical association, 
perhaps by intercalation, with Salmonella DNA. 
The data are in agreement with a recent report of 
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Masuda and Ueno (1984) showing that a 2-
hydroxylation can activate an anthraquinone ring 
system to a mutagen for TA1537 requiring no 
further activation. 
The data on rat-liver DNA bindingalso suggest 
that an intact mammalian liver is unlikely to be 
able to activate emodin to metabolites which could 
react covalently with DNA to any appreciable 
extent. 
An assessment of the carcinogenic risk to hu-
mans from exposure to emodin and to structurally 
related anthraquinone mutagens must therefore 
take the following into account: (i) The mutagen-
icity of emodin in stram TA1537 which was also 
reported for other anthraquinones (Brown and 
Dietrich, 1976) is not due to covalent binding of 
the compound to Salmonella DNA. (ii) We are 
not aware of any report showing that a mutagen 
which exclusively reverts strain TA1537 has 
carcinogenic activity in animals.· (iii) No relation-
ship exists between intercalative mutagenicity in 
short-term assays and carcinogenicity. 
Dibenz[ a, h ]an thracene-5 ,6-oxide, a mutagen 
which was reported to be also positive only in S. 
typhimurium TA1537, is not an animal carcinogen 
(Grover et al., 1975). Chloroquin and quinacrin 
showing the same spectruin of mutagenic activity 
most probably have no carcinogenic activity 
(Fitzhugh et al., 1945, 1948). (üü) There is no 
conclusive evidence for a carcinogenic activity in 
animals for anthraquinone derivatives such as 
hydroxyanthraquinones, whereas carcinogenicity 
has been reported for an anthraquinone bearing a 
nitro group, 2-methyl-1-nitroanthraquinone 
(Murthy et al., 1979). In addition, nitroanthra-
quinones are mutagenic in Salmonella strains 
TA98, TA1538 and TA100 thus showing a differ-
ent pattem of mutagenic activity as compared 
with emodin (Brown and Brown, 1976; Brown and 
Dietrich, 1979). 
Despite the positive results in the Ames test, 
our analysis suggests that emodin is unlikely to 
represent a high priority risk in human mutagen 
exposure. 
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